North America Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) and By Country (US, Canada) Forecasts, 2025-2033

Last Updated: November 14, 2022 | Author: Debashree B | Format: | Report Code: SRHI3178DR | Pages: 80

Market Segmentation

  • North America Neurodegenerative Disease Market, By Disease Indication (2021-2033)
    1. Multiple Sclerosis
    2. Parkinson's Disease
    3. Alzheimer's Disease
    4. Others
  • North America Neurodegenerative Disease Market, By Drug Type (2021-2033)
    1. Immunomodulator
    2. Vesicular Monoamine Transporter 2 (VMAT2)
    3. Others
  • North America Neurodegenerative Disease Market, By Routes of Administration (2021-2033)
    1. Oral
    2. Intravenous (IV) delivery
    3. Others

    Download Free Sample

    Our Clients:

    LG Electronics
    AMCAD Engineering
    KOBE STEEL LTD.
    Hindustan National Glass & Industries Limited
    Voith Group
    International Paper
    Hansol Paper
    Whirlpool Corporation
    Sony
    Samsung Electronics
    Qualcomm
    Google
    Fiserv
    Veto-Pharma
    Nippon Becton Dickinson
    Merck
    Argon Medical Devices
    Abbott
    Ajinomoto
    Denon
    Doosan
    Meiji Seika Kaisha Ltd
    LG Chemicals
    LCY chemical group
    Bayer
    Airrane
    BASF
    Toyota Industries
    Nissan Motors
    Neenah
    Mitsubishi
    Hyundai Motor Company

    We are featured on: